Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)
Wagner, Michael J, Othus, Megan, Patel, Sandip P, Ryan, Chris, Sangal, Ashish, Powers, Benjamin, Budd, G Thomas, Victor, Adrienne I, Hsueh, Chung-Tsen, Chugh, Rashmi, Nair, Suresh, Leu, Kirsten M, Agulnik, Mark, Sharon, Elad, Mayerson, Edward, Plets, Melissa, Blanke, Charles, Streicher, Howard, Chae, Young Kwang, Kurzrock, Razelle
Published in Journal for immunotherapy of cancer (01.08.2021)
Published in Journal for immunotherapy of cancer (01.08.2021)
Get full text
Journal Article
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial
VanderWalde, Ari, Bellasea, Shay L., Kendra, Kari L., Khushalani, Nikhil I., Campbell, Katie M., Scumpia, Philip O., Kuklinski, Lawrence F., Collichio, Frances, Sosman, Jeffrey A., Ikeguchi, Alexandra, Victor, Adrienne I., Truong, Thach-Giao, Chmielowski, Bartosz, Portnoy, David C., Chen, Yuanbin, Margolin, Kim, Bane, Charles, Dasanu, Constantin A., Johnson, Douglas B., Eroglu, Zeynep, Chandra, Sunandana, Medina, Egmidio, Gonzalez, Cynthia R., Baselga-Carretero, Ignacio, Vega-Crespo, Agustin, Garcilazo, Ivan Perez, Sharon, Elad, Hu-Lieskovan, Siwen, Patel, Sapna P., Grossmann, Kenneth F., Moon, James, Wu, Michael C., Ribas, Antoni
Published in Nature medicine (01.09.2023)
Published in Nature medicine (01.09.2023)
Get full text
Journal Article
Management of melanoma in patients with chronic lymphocytic leukemia
Archibald, William J., Meacham, Philip J., Williams, AnnaLynn M., Baran, Andrea M., Victor, Adrienne I., Barr, Paul M., Sahasrahbudhe, Deepak M., Zent, Clive S.
Published in Leukemia research (01.08.2018)
Published in Leukemia research (01.08.2018)
Get full text
Journal Article
Merkel Cell Carcinoma: Characteristics, Management, and What’s on the Horizon
Victor, Adrienne I., MD, MS (Biochemistry), Sahasrabudhe, Deepak M., MD
Published in Clinical skin cancer (01.04.2016)
Published in Clinical skin cancer (01.04.2016)
Get full text
Journal Article
Safety and efficacy of first-in-class CXCR1/2 inhibitor SX-682 in combination with pembrolizumab (pem) in patients (pts) with metastatic melanoma (mMEL) with disease progression on anti–PD-1 therapy
Patel, Sapna Pradyuman, Dimou, Anastasios, Victor, Adrienne I., Mooradian, Meghan, Buchbinder, Elizabeth Iannotti, Hernandez-Aya, Leonel Fernando, Prieto, Peter A., Cohen, Justine Vanessa, Flaherty, Keith, Kahn, Stuart, Schuler, Aaron, Maeda, Dean, Zebala, John
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
Abstract CT013: S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with metastatic or unresectable melanoma that did not respond to anti-PD-1 therapy
Vanderwalde, Ari M., Moon, James, Kendra, Kari, Khushalani, Nikhil I., Collichio, Frances, Sosman, Jeffrey A., Ikeguchi, Alexandra, Victor, Adrienne I., Truong, Thach-Giao, Chmielowski, Bartosz, Portnoy, David C., Wu, Michael C., Grossmann, Kenneth F., Ribas, Antoni
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Abstract 6550: Biopsy analysis of trial S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with anti-PD-1 refractory melanoma
Campbell, Katie M., Bustami, Zaid, Chen, Daniel G., Medina, Egmidio, Gonzalez, Cynthia R., Aldeen, Nataly Naser, Baselga-Carretero, Ignacio, Vega-Crespo, Agustin, Maxey, Jessica, Chen, Jia M., Kuklinski, Lawrence F., Kendra, Kari L., Chmielowski, Bartosz, Truong, Thach-Giao, Khushalani, Nikhil I., Collichio, Frances, Ikeguchi, Alexandra, Victor, Adrienne I., Margolin, Kim, Sosman, Jeffrey A., Patel, Sapna P., Hu-Lieskovan, Siwen, Moon, James, Bellasea, Shay, Wells, Daniel K., Spencer, Christine N., Thompson, Marshall A., Wu, Michael, Scumpia, Philip O., VanderWalde, Ari, Ribas, Antoni
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article